Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients

Ruey Hsing Chou, Shang Feng Yang, Po Hsun Huang^*

^*此作品的通信作者

研究成果: Letter › 同行評審

存取文件

@article{3eb7948ed9a84f5fb72d95c55b0c33d5,

title = "Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients",

author = "Chou, {Ruey Hsing} and Yang, {Shang Feng} and Huang, {Po Hsun}",

year = "2024",

doi = "10.6515/ACS.202403_40(2).20231206B",

language = "English",

volume = "40",

pages = "260--261",

journal = "Acta Cardiologica Sinica",

issn = "1011-6842",

publisher = "Republic of China Society of Cardiology",

number = "2",

}

TY - JOUR

T1 - Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients

AU - Chou, Ruey Hsing

AU - Yang, Shang Feng

AU - Huang, Po Hsun

PY - 2024

Y1 - 2024

UR - http://www.scopus.com/inward/record.url?scp=85188597258&partnerID=8YFLogxK

U2 - 10.6515/ACS.202403_40(2).20231206B

DO - 10.6515/ACS.202403_40(2).20231206B

M3 - Letter

AN - SCOPUS:85188597258

SN - 1011-6842

VL - 40

SP - 260

EP - 261

JO - Acta Cardiologica Sinica

JF - Acta Cardiologica Sinica

IS - 2

ER -